Skip to main content
Clinical Trials/NCT00785720
NCT00785720CompletedPhase 3

Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Sanofi1 site in 1 country26 target enrollmentStarted: August 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Sanofi
Enrollment
26
Locations
1
Primary Endpoint
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.

Study Overview

Brief Summary

The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Sweet Flower.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Experimental

Dermacyd PH_DETINBACK (Lactic Acid)

Intervention: Dermacyd PH_DETINBACK (Lactic Acid) (Drug)

Outcomes

Primary Outcomes

The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.

Time Frame: Throughout the study

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sanofi
Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials